Skip to main content
Ingredients/Probiotic/Clostridium Butyricum-Containing Probiotic

Clostridium Butyricum-Containing Probiotic.

Read pending.Clostridium Butyricum-Containing Probiotic is in the library; the clinical read is in the queue.

Research-backed probiotic with potential health benefits. Produces butyrate directly in your colon. This strengthens the gut lining, reduces inflammation, and fuels your colon cells.

1,000,000,000 to 10,000,000,000 CFUDaily amount

Reviewed March 2026

CBProbiotic
Clostridium Butyricum-Containing ProbioticIngredientMD
Category
Probiotic

What Clostridium Butyricum-Containing Probiotic is, and what it does.

Does it work
Yes, for targeted gut support. If you have specific gut issues or want to support your gut barrier, the evidence is solid. Less of a general-purpose probiotic.
How much to take
Look for products with specific strains, like MIYAIRI 588. Doses often range from 20-100 million CFU per day. Follow the product label.
Time to feel it
Spores germinate in the colon within a day or two, but changes in regularity and comfort usually build across two to four weeks of daily use.
The first dose
Nothing. Probiotics take time to establish themselves and have an effect. Be patient.
With regular use
After a month, you might see improved regularity and reduced gut irritation. It's about creating a healthier gut environment over time.
How well tolerated
Well tolerated for most. Its spore form makes it tough. The main caution is for the severely immunocompromised, but that's a rule for all live bacteria.
How it feels
Subtle. You don't feel it working. You just notice your gut feels more resilient and predictable over weeks.
The overlooked benefit
Colon cells burn the butyrate it makes, and that oxygen use keeps the lining oxygen-poor, which is exactly the environment your other resident anaerobes need.

1,000,000,000 to 10,000,000,000 CFU a day is where Clostridium Butyricum-Containing Probiotic works.

How much to take a dayMedium confidence
1,000,000,000 to 10,000,000,000 CFU
Daily maintenanceThe everyday amount, and where most daily supplements sit. This is the one you take month after month.
50,000,000,000 CFUClinical territory. Trials run high on purpose, for a set number of weeks, against one measured outcome. Impressive to hit, and not what a daily product is for.
Above 100,000,000,000 CFUPast what the research covers. More capsules rather than more effect.
MORE EFFECT ↑010,000,000,000 CFU50,000,000,000 CFU plateauDAILY DOSE →
The shaded band is where the dosing trials landed.

Source: ISAPP consensus statement 2019 + Ford 2014 meta-analysis

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

Read pending.

Clostridium Butyricum-Containing Probiotic is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.

  • butyrate production from undigested carbohydrate in the colonIn vitro study
  • bowel regularity and stool consistencyRandomised trial
  • gut barrier integrityAnimal study
  • microbiome composition after a course of antibioticsRandomised trial
  • survival through gastric acid without enteric coatingIn vitro study
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.

Questions people ask about Clostridium Butyricum-Containing Probiotic.

How is this different from other probiotics?
It makes butyrate directly. Most others make lactate. Butyrate is the preferred fuel for your colon cells.
Do I need to keep it in the fridge?
Usually no. Its spore form makes it very stable at room temperature. A big plus.
Will it cause gas or bloating?
Maybe for the first few days. It's a sign your gut bacteria are adjusting. It usually settles down quickly.
What does 'spore-forming' mean?
It has a hard, protective shell. This helps it survive stomach acid and reach your colon intact, ready to work.
Is this a 'soil-based' probiotic?
Yes, that's another name for spore-forming probiotics like this one. They are found naturally in soil and the gut.
Pairs well with20 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

The organism is defined by what it makes: butyrate from the fermentation of undigested carbohydrate in the colon. A supplemental butyrate salt delivers the same short chain fatty acid directly, though most of an unprotected oral dose is absorbed before the distal colon. One approach supplies the molecule, the other supplies a resident producer of it.

Clostridium butyricum makes butyrate only when fermentable carbohydrate reaches it, and inulin is a defined fructan that resists human digestive enzymes and arrives in the colon intact. Pairing a producer with its substrate is the standard synbiotic construction. The mechanism is settled even where the specific pair has not been trialled.

Resistant starch is the substrate most strongly associated with colonic butyrate production, since the primary degraders release fragments that butyrate producers then use. Adding a butyrate-forming organism alongside it targets the second half of that chain. This is cross-feeding, a well described feature of colonic fermentation.

Short-chain fructans are fermented rapidly in the proximal colon and support the saccharolytic community that butyrate producers depend on. Speed is the trade-off: rapid fermentation concentrates gas production early in the colon. The substrate relationship itself is not in doubt.

Galactooligosaccharides are fermented preferentially by bifidobacteria, which release lactate and acetate that butyrate producers convert onward. The pairing works through cross-feeding rather than by feeding the butyrate producer directly. That indirect route is well characterised in colonic fermentation studies.

Partially hydrolysed guar gum ferments slowly and further along the colon than the short fructans, which spreads substrate availability across a longer stretch of bowel. For a butyrate-forming organism that means fermentable material where it matters. It is also better tolerated at higher intakes than the rapidly fermented substrates.

Psyllium is only partly fermented and acts largely as a gel-forming bulking fibre, so it changes transit and stool water alongside a modest fermentable fraction. Combined with a butyrate producer it addresses bulk and fermentation separately. The two effects should not be described as one.

Oat beta-glucan is a viscous soluble fibre fermented in the colon to short chain fatty acids including butyrate. It supplies substrate while also slowing gastric emptying higher up. Both effects come from the same molecule and are worth stating separately.

Glutamine is the preferred fuel of the small intestinal enterocyte while butyrate is the preferred fuel of the colonocyte. The two feed different segments of the same epithelium. A formula carrying both is covering the whole length rather than doubling one input.

Bifidobacteria ferment carbohydrate to acetate and lactate, which butyrate-producing organisms take up and convert to butyrate through the butyryl-CoA:acetate CoA-transferase route. That is textbook cross-feeding and it is why multi-genus blends are built the way they are. The pair is complementary rather than redundant.

Lactate from lactobacilli is a substrate for lactate-utilising butyrate producers, so the two genera occupy successive steps of one fermentation chain. Blends pairing them are exploiting that hand-off. The mechanism is established even where the specific strain combination has not been trialled.

The yeast is not affected by antibacterial agents that suppress bacterial strains, and a spore-forming bacterium survives conditions that vegetative strains do not. Products combining them are covering two different survival profiles in one capsule. Each has its own literature and the blend has not been tested as a unit.

Zinc carnosine is used for its adherence to the gastrointestinal mucosal surface and its role in normal epithelial repair, while butyrate supplies the colonocyte its main energy substrate. Both act on the barrier from different angles. This is a mechanistic pairing, not a tested combination.

Lactoferrin sequesters iron and so shapes which organisms can grow in the gut lumen, and it has been described as bifidogenic. Placed with a probiotic it changes the competitive environment that strain lands in. The direction of that effect depends on the wider community, so it is modulating rather than plainly additive.

Vitamin D receptor signalling in intestinal epithelium influences tight junction protein expression and antimicrobial peptide production, which is the host side of the barrier a probiotic acts on from the lumen. Host and lumen are separate inputs to one structure. The pairing is mechanistic and drawn from host physiology rather than from a combination trial.

Carvacrol and thymol are broadly antibacterial and do not distinguish a supplemented organism from a resident one. Taken in the same window as a live culture they reduce the viable count that arrives. Separating them by several hours, or sequencing them, is the usual practice.

Activated charcoal adsorbs organic material indiscriminately across a very large surface area, including bacterial cells and the fermentable substrate they need. Co-administration undercuts both halves of a synbiotic. Spacing doses by several hours is the standard answer.

Bentonite is a binding clay with a high cation exchange capacity that adsorbs a wide range of luminal contents. Given alongside a live culture it reduces what reaches the colon intact. The interaction is physical adsorption rather than any biological antagonism.

Berberine has direct antibacterial activity and reproducibly shifts gut microbial composition in animal and human work. Given with a probiotic it alters the community the strain is entering rather than simply killing it. The net direction depends on the strain and on the baseline community, so it is worth flagging rather than recommending.

Bovine colostrum carries immunoglobulins and oligosaccharides that both bind pathogens and act as fermentable substrate. That gives a live culture both a substrate and a modified luminal environment. The rationale is compositional and the pairing has not been tested as such.

Who should be cautious

Nothing specific on file for Clostridium Butyricum-Containing Probiotic. Match the label to the daily amount above, and tell your doctor what you take.

Not medical advice. Show the label to your pharmacist.

What Clostridium Butyricum-Containing Probiotic actually does.

Established

Clostridium butyricum is a spore-forming bacterium that lives without oxygen and ferments carbohydrate your gut didn't digest into butyrate, acetate, carbon dioxide and hydrogen.

Established

Because it forms tough spores, it gets through stomach acid and bile without the special coatings most lactobacilli and bifidobacteria need, then wakes up once it reaches the oxygen-free colon.

Established

Butyrate is the main fuel of the cells lining your colon, covering most of their energy needs. Those cells burn it on the spot, which is why little colonic butyrate makes it into the bloodstream.

Established

At normal colon concentrations butyrate blocks histone deacetylase enzymes and switches on the short chain fatty acid receptors GPR41, GPR43 and GPR109A, which is how a fermentation product becomes a signal.

Fermented, 6 steps on record

Where Clostridium Butyricum-Containing Probiotic comes from.

One specific bacterial strain is grown in a sealed oxygen-free tank, then pushed to form spores, which are the tough dormant version. The spores are spun out, washed, freeze dried into a powder and counted so each capsule carries a stated number of live organisms.

Built by fermentation, the same way vitamin B12 and many amino acids are made at scale. Controlled conditions, consistent output.

Starts as
Defined anaerobic growth medium

A carbohydrate source with a nitrogen source such as yeast extract or peptone, plus minerals and a reducing agent to hold the medium anaerobic.

Converted by
Anaerobic tank fermentation of a banked strain

A single deposited strain is drawn from a master cell bank and grown in sealed anaerobic fermenters with pH and temperature control; at the end of the run conditions are shifted to drive sporulation, since spores rather than vegetative cells are the shelf-stable product.

Extracted by
Harvest and concentration

Biomass is separated from spent broth by centrifugation or membrane filtration and washed to remove medium residues.

Purified by
Wash and cryoprotectant blending

The concentrate is washed again and blended with a cryoprotectant so the spore coat survives the freezing and drying steps intact.

Standardised to
CFU assay and dilution to potency

Viable count is measured by anaerobic plate culture and the powder is diluted with carrier to a declared CFU per gram, with identity confirmed genetically and a purity check for contaminating organisms.

Ends up as
Lyophilisation, blending and filling

The blend is freeze dried, milled to a uniform particle size and packed under low moisture, since water activity is the main driver of viability loss on the shelf.

Getting Clostridium Butyricum-Containing Probiotic from food.

The whole-food sources on file. A supplement closes the gap, it does not replace dinner.

SoilThe healthy human gut

A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.

The forms it comes in.

Freeze-dried spore powderHarvested culture washed, blended with a cryoprotectant such as trehalose or skimmed milk solids and lyophilised, then standardised to a CFU per gram figure.Fits Capsules, sachets and blends where a declared CFU count and a long ambient shelf life are the specification.Trade-off CFU declines over shelf life, so the label figure has to be either an end-of-life count or a manufacture-date count and the two are not interchangeable.
What the strongest studies found

The essence, in one line each.

  1. The review sets out how Clostridium butyricum and its metabolites, chiefly butyrate, modulate gut mucosal immunity through regulatory T cell induction and epithelial barrier signalling; it synthesises mechanism rather than reporting a new measurement.Narrative review. Qian et al., 2026 (Frontiers in Immunology). PMID 41789065
  2. Metagenomic sequencing showed that Clostridium butyricum with Bacillus subtilis shifted gut microbial community composition in birds; the endpoint is a community-composition measure, not a health outcome.Animal study. Sitthipunya et al., 2026 (Poultry Science). PMID 41539238
  3. A three-strain mixture including Clostridium butyricum improved growth measures in broiler chicks; the strains were fed together, so no effect can be attributed to any one of them.Animal study. Dang et al., 2024 (Probiotics and Antimicrobial Proteins). PMID 36512203
  4. Strain RH2 improved stool consistency measures in juvenile mice held under continuous antibiotic exposure, alongside changes in microbial composition; the finding is in animals and strain-specific.Animal study. Zhao et al., 2026 (Microbiology Spectrum). PMID 41498557
  5. A spore-forming probiotic blend was measured against bowel habit and physical well-being scores in adults with infrequent bowel movements; the organism is one component of the blend and was not tested alone.Randomised trial. Park et al., 2026 (PLOS One). PMID 42030329
  6. In a single-centre randomised controlled trial, perioperative administration of the CBM588 preparation was associated with differences in postoperative gut microbiota composition and recovery measures; microbiota composition is a marker, not an outcome.Randomised trial. Yang et al., 2025 (Cell Reports Medicine). PMID 40633539
  7. A multi-species probiotic including butyrate-forming organisms altered growth and stress response markers in farmed fish; the ingredient is named among the species used and the work is not human evidence.Animal study. Jamil et al., 2026 (Probiotics and Antimicrobial Proteins). PMID 42348161

These are the studies our verdict leans on, chosen from the 7 we read for Clostridium Butyricum-Containing Probiotic. The full linked list is below.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.